Results 151 to 160 of about 13,475,824 (303)

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Factors associated with Peruvian students' knowledge of non-steroidal anti-inflammatory drug management in pediatric dentistry: a cross-sectional study. [PDF]

BMC Med Educ
Alvarado-Cotrina N, Ladera-Castañeda M, Turpo-Claudio D, Cervantes-Ganoza L, Yarasca-Berrocal E, Huamani-Echaccaya J, Cayo-Rojas C.   +6 more
europepmc   +1 more source

Utilization of Technology to Improve Efficiency in Investigational Drug Management Processes. [PDF]

J Pharm Technol, 2020
Mudaranthakam DP, Cernik C, Curtis L, Griffith B, Hu J, Wick J, Thompson J, Gajewski B, Koestler D, Jensen RA, Mayo MS.   +10 more
europepmc   +1 more source

Drug management in the elderly adult with chronic kidney disease: a review for the primary care physician.

Mayo Clinic proceedings, 2015
C. Ponticelli, Gabriele Sala, R. Glassock   +2 more
semanticscholar   +1 more source

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

Polypharmacy driven synergistic toxicities in elderly breast cancer chemotherapy drug management and adverse drug reactions: a mini review. [PDF]

Front Pharmacol
Wang X, Yang J, Zhang J, Yang H.
europepmc   +1 more source

Nationwide Survey of Association Between Fever and Epileptic Seizure in CDKL5 Deficiency Disorder Revealed Therapeutic Implications

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective CDKL5 deficiency disorder (CDD) is a rare, severe developmental and epileptic encephalopathy. There is a pressing need to develop effective and sustainable therapeutic strategies. We aimed to investigate the causal association between febrile episodes and epileptic seizures for therapeutic implications in CDD patients.
Siyi Wang, Jialin Du, Jinghui Liu, Dongmei Hu, Hongxin Wang, Xiaoxiao Man, Lehong Gao, Shimin Hu, Xianghong Meng, Hongyang Zhao, Minjing Hu, Yingxue Yang, Zhiqi Xiong, Liankun Ren   +13 more
wiley   +1 more source

Fifteen-year trends in diabetes drug management and control in French-speaking Switzerland. [PDF]

Diabetol Metab Syndr
Pauli A, Alkandari A, Marques-Vidal P.
europepmc   +1 more source

Perioperative drug management in non-critical companion animals: a retrospective study at a Spanish veterinary teaching hospital (2018-2022). [PDF]

Vet Q
Romero B, Susperregui J, Sahagún AM, Altónaga JR, López C, de la Puente R, Rodríguez JM, Vázquez M, Díez R.   +8 more
europepmc   +1 more source

Antiepileptic Drug Management in Acute Ischemic Stroke: Are Vascular Neurologists Utilizing Electroencephalograms? An Observational Cohort Study. [PDF]

Biomed Res Int, 2020
Rao R, Monlezun DJ, Kimbrough T, Burkett BJ, Samai A, Martin-Schild S.   +5 more
europepmc   +1 more source